<DOC>
	<DOC>NCT02790281</DOC>
	<brief_summary>The purpose of this study is to measure IL-6 and IL-6/sIL-6R complex levels in subjects with active moderate to severe ulcerative colitis or Crohn's disease.</brief_summary>
	<brief_title>A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects With Active Inflammatory Bowel Disease</brief_title>
	<detailed_description />
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Subjects diagnosed with active moderate to severe ulcerative colitis (*partial Mayo ≥ 5) or Crohn's disease (Harvey &amp; Bradshaw ≥ 8) *partial Mayo: 9point scale that excludes the endoscopic components of the Mayo score Presence of another inflammatory disease, except for mild cutaneous psoriasis Concomitant gastrointestinal infection or otherwise serious infection including Crohn's disease infectious complication Treatment with Infliximab, Adalimumab, Certolizumab Pegol or other immunemodulating biologics within 8 weeks prior to the visit Having a known or suspected gastrointestinal or otherwise serious infection within 8 weeks prior to the visit Concomitant diagnosed or suspected malignant disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>